Alterity Price To Sales Ratio from 2010 to 2024

ATHE Stock  USD 1.87  0.01  0.53%   
Alterity Therapeutics' Price To Sales Ratio is increasing over the years with slightly volatile fluctuation. Overall, Price To Sales Ratio is expected to go to 3,707 this year. Price To Sales Ratio is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
3.5 K
Current Value
3.7 K
Quarterly Volatility
1.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Alterity Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alterity main balance sheet or income statement drivers, such as Interest Expense of 2.9 K, Other Operating Expenses of 9.7 M or Total Operating Expenses of 9.7 M, as well as many exotic indicators such as Price To Sales Ratio of 3.7 K, Dividend Yield of 0.0 or PTB Ratio of 424. Alterity financial statements analysis is a perfect complement when working with Alterity Therapeutics Valuation or Volatility modules.
  
This module can also supplement various Alterity Therapeutics Technical models . Check out the analysis of Alterity Therapeutics Correlation against competitors.
For information on how to trade Alterity Stock refer to our How to Trade Alterity Stock guide.

Latest Alterity Therapeutics' Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Alterity Therapeutics over the last few years. Price to Sales Ratio is figured by comparing Alterity Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Alterity Therapeutics sales, a figure that is much harder to manipulate than other Alterity Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. Alterity Therapeutics' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alterity Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 7.48 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Alterity Price To Sales Ratio Regression Statistics

Arithmetic Mean1,212
Geometric Mean376.31
Coefficient Of Variation136.02
Mean Deviation1,395
Median295.66
Standard Deviation1,649
Sample Variance2.7M
Range4.1K
R-Value0.69
Mean Square Error1.5M
R-Squared0.47
Significance0
Slope253.98
Total Sum of Squares38.1M

Alterity Price To Sales Ratio History

2024 3707.1
2023 3530.57
2022 3922.86
2021 4149.0
2020 11.3
2019 43.12
2018 121.03

About Alterity Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Alterity Therapeutics income statement, its balance sheet, and the statement of cash flows. Alterity Therapeutics investors use historical funamental indicators, such as Alterity Therapeutics's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Alterity Therapeutics investors may use each financial statement separately, they are all related. The changes in Alterity Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Alterity Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Alterity Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Alterity Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio3.5 K3.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Alterity Therapeutics is a strong investment it is important to analyze Alterity Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alterity Therapeutics' future performance. For an informed investment choice regarding Alterity Stock, refer to the following important reports:
Check out the analysis of Alterity Therapeutics Correlation against competitors.
For information on how to trade Alterity Stock refer to our How to Trade Alterity Stock guide.
Note that the Alterity Therapeutics information on this page should be used as a complementary analysis to other Alterity Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Alterity Stock analysis

When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Global Correlations
Find global opportunities by holding instruments from different markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is Alterity Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alterity Therapeutics. If investors know Alterity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alterity Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.75)
Revenue Per Share
0.6
Quarterly Revenue Growth
(0.20)
Return On Assets
(0.29)
Return On Equity
(0.54)
The market value of Alterity Therapeutics is measured differently than its book value, which is the value of Alterity that is recorded on the company's balance sheet. Investors also form their own opinion of Alterity Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Alterity Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alterity Therapeutics' market value can be influenced by many factors that don't directly affect Alterity Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alterity Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alterity Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alterity Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.